Oracle (NYSE:ORCL) Price Target Increased to $131.00 by Analysts at Evercore ISI

Oracle (NYSE:ORCL) had its target price lifted by Evercore ISI from $125.00 to $131.00 in a report released on Tuesday morning, MarketBeat.com reports. Evercore ISI currently has an in-line rating on the enterprise software provider’s stock.

ORCL has been the topic of a number of other reports. Guggenheim raised their price objective on Oracle from $120.00 to $150.00 in a research note on Tuesday, June 13th. Stifel Nicolaus boosted their price target on Oracle from $84.00 to $120.00 in a research note on Tuesday, June 13th. Barclays cut their price objective on Oracle from $150.00 to $147.00 and set an overweight rating for the company in a research report on Tuesday. Jefferies Financial Group boosted their target price on Oracle from $135.00 to $145.00 and gave the stock a buy rating in a research report on Thursday, September 7th. Finally, Piper Sandler restated an overweight rating and set a $130.00 target price on shares of Oracle in a research report on Thursday, July 27th. Twelve investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average target price of $122.48.

Oracle Stock Down 13.5 %

ORCL opened at $109.61 on Tuesday. Oracle has a fifty-two week low of $60.78 and a fifty-two week high of $127.54. The business has a 50-day moving average of $117.41 and a 200-day moving average of $105.85. The company has a debt-to-equity ratio of 55.54, a current ratio of 0.91 and a quick ratio of 0.91. The company has a market capitalization of $297.51 billion, a PE ratio of 35.82, a price-to-earnings-growth ratio of 3.48 and a beta of 1.00.

Oracle (NYSE:ORCL) last posted its quarterly earnings results on Monday, September 11th. The enterprise software provider reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.15 by $0.04. Oracle had a negative return on equity of 470.73% and a net margin of 17.02%. The company had revenue of $12.45 billion during the quarter, compared to the consensus estimate of $12.48 billion. During the same period last year, the business earned $0.81 EPS. The business’s quarterly revenue was up 8.8% on a year-over-year basis. Equities research analysts forecast that Oracle will post 4.5 EPS for the current fiscal year.

Oracle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 26th. Shareholders of record on Thursday, October 12th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.46%. Oracle’s dividend payout ratio is 52.29%.

Insider Buying and Selling at Oracle

In other news, Chairman Lawrence Joseph Ellison sold 1,750,000 shares of the stock in a transaction that occurred on Thursday, June 22nd. The stock was sold at an average price of $120.95, for a total transaction of $211,662,500.00. Following the transaction, the chairman now owns 1,145,732,353 shares in the company, valued at $138,576,328,095.35. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Oracle news, Director Jeffrey Berg sold 4,866 shares of the firm’s stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $125.31, for a total value of $609,758.46. Following the sale, the director now owns 207,409 shares of the company’s stock, valued at approximately $25,990,421.79. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Chairman Lawrence Joseph Ellison sold 1,750,000 shares of the firm’s stock in a transaction on Thursday, June 22nd. The shares were sold at an average price of $120.95, for a total value of $211,662,500.00. Following the completion of the sale, the chairman now directly owns 1,145,732,353 shares in the company, valued at approximately $138,576,328,095.35. The disclosure for this sale can be found here. Insiders have sold 4,175,443 shares of company stock worth $510,658,596 over the last 90 days. Company insiders own 43.70% of the company’s stock.

Institutional Investors Weigh In On Oracle

Several hedge funds have recently modified their holdings of ORCL. Fairfield Bush & CO. raised its position in Oracle by 3.1% during the 1st quarter. Fairfield Bush & CO. now owns 73,791 shares of the enterprise software provider’s stock worth $6,105,000 after purchasing an additional 2,221 shares during the last quarter. AMI Investment Management Inc. boosted its stake in Oracle by 2.9% during the 1st quarter. AMI Investment Management Inc. now owns 20,467 shares of the enterprise software provider’s stock valued at $1,693,000 after purchasing an additional 579 shares during the last quarter. Baird Financial Group Inc. boosted its stake in shares of Oracle by 29.2% in the 1st quarter. Baird Financial Group Inc. now owns 588,460 shares of the enterprise software provider’s stock worth $48,686,000 after buying an additional 132,920 shares during the last quarter. Zions Bancorporation N.A. boosted its stake in shares of Oracle by 79.6% in the 1st quarter. Zions Bancorporation N.A. now owns 6,854 shares of the enterprise software provider’s stock worth $567,000 after buying an additional 3,038 shares during the last quarter. Finally, Covestor Ltd boosted its stake in shares of Oracle by 125.2% in the 1st quarter. Covestor Ltd now owns 1,995 shares of the enterprise software provider’s stock worth $165,000 after buying an additional 1,109 shares during the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.